Search Results for “AI” – Page 622 – media

Roche reports strong performance in the first half of 2017

Commenting on the Group’s results, Roche CEO Severin Schwan said: “In the first half of the year, both our Pharmaceuticals and Diagnostics Divisions showed strong performance, very much driven by new product launches. Particularly pleasing is the very successful launch of Ocrevus for the treatment of two forms of multiple sclerosis. Based on our half-year performance, we raised the outlook for the full-year to mid-single digit sales growth.”
- Source: www.roche.com
- 512
- August 4, 2017
Company Insight
10th International Conference on Clinical and Surgical Ophthalmology

Location: New South Wales, Australia Venue Address: DoubleTree by Hilton Beijing 168 Guang An Men Wai Avenue Xi Cheng District Beijing China Date: 07 Aug,2017 – 09 Aug,2017 Organizer: Sarika James Brief Conference Series LLC cordially invites you to participate at the 10th International Conference on Clinical and Surgical Ophthalmology to be held during August 07-09, 2017 at Beijing, China. The theme of the conference is “Exploring the novel research and trends in clinical and surgical ophthalmology” which focuses on the significance of vision and also explore the spectrum of latest technological developments in the field of Ophthalmology. Ophthalmology Conference 2017 maximizes the opportunity to interact with and learn from your peers from across the country and across the globe. Detailed Description: Conference Series LLC cordially invites you to participate at the 10th International Conference on Clinical and Surgical Ophthalmology to be held during August 07-09, 2017 at Beijing, China. ...
- Source: medical-events
- 624
- August 4, 2017
Clinical Exhibitions & Activities surgical
GSK delivers further progress in Q2 and sets out new priorities for the Group

GSK delivers further progress in Q2 and sets out new priorities for the Group
- Source: www.gsk.com/
- 378
- August 4, 2017
Company Insight
Johnson & Johnson Reports 2017 Second-Quarter Results

New Brunswick, N.J. (July 18, 2017) – Johnson & Johnson (NYSE: JNJ) today announced sales of $18.8 billion for the second quarter of 2017, an increase of 1.9% as compared to the second quarter of 2016. Operational sales results increased 2.9% and the negative impact of currency was 1.0%. Domestic sales increased 1.6%. International sales increased 2.3%, reflecting operational growth of 4.4% and a negative currency impact of 2.1%. Excluding the net impact of acquisitions and divestitures, on an operational basis, worldwide sales increased 0.5%, domestic sales decreased 1.0% and international sales increased 2.0%.*
- Source: www.jnj.com
- 596
- August 4, 2017
Company Insight
Asuragen launches new response monitoring kit for CML

US-based molecular diagnostics firm Asuragen has launched the QuantideX qPCR BCR-ABL minor Kit designed to monitor molecular response in patients with chronic myeloid leukaemia (CML).
- Source: drugdu
- 423
- August 4, 2017
CML Company Insight inhibitor leukaemia
UK’s University of Bristol develops new test to fight antibiotic resistance

Researchers at the University of Bristol in the UK have developed a new technology to aid general practitioners in prescribing antibiotics and to assist in fighting antibiotic resistance.
- Source: medicaldevices-network.com
- 465
- August 4, 2017
antibiotic resistance Researches
Diabetes prescriptions rocket 80 percent in a decade

Growth in prescriptions for diabetes medicines is exceeding the rise in overall prescribing, according to new figures from NHS Digital.
- Source: pharmatimes
- 556
- August 3, 2017
diabetes Market Views Researches
UC Riverside tests new biopsy device for cervical cancer

A research team at the University of California, Riverside (UC Riverside) in the US has evaluated a new device manufactured by tissue sampling devices maker Histologics.
- Source: medicaldevices-network.com
- 467
- August 3, 2017
cancer cervical Clinical Trials Researches
Sciex launches new LC-MS clinical diagnostic system

US-based Sciex Diagnostics has launched a new fully integrated LC-MS solution, Sciex Topaz System, for use in clinical diagnostics.
- Source: medicaldevice-network.com
- 552
- August 2, 2017
Company Insight diagnostic Sciex
Emergent secures $23m to develop new auto-injector for US’ DoD

US-based life sciences firm Emergent BioSolutions has secured around $23m for the development of a new multi-drug auto-injector to deliver nerve agent antidote.
- Source: medicaldevice-network.com
- 426
- August 2, 2017
antidote FDA Market Views

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.